Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cytokinetics, Incorporated - Common Stock
(NQ:
CYTK
)
66.73
+0.12 (+0.18%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cytokinetics, Incorporated - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
Securities Fraud Investigation Into Cytokinetics, Incorporated (CYTK) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
May 08, 2025
From
Glancy Prongay & Murray LLP
Via
Business Wire
Cytokinetics, Incorporated (CYTK) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
May 08, 2025
From
Law Offices of Howard G. Smith
Via
Business Wire
Securities Fraud Investigation Into Cytokinetics, Incorporated (CYTK) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
May 07, 2025
From
Law Offices of Frank R. Cruz
Via
Business Wire
Earnings Scheduled For May 6, 2025
↗
May 06, 2025
Via
Benzinga
Earnings Scheduled For February 27, 2025
↗
February 27, 2025
Via
Benzinga
CYTK Investors Have Opportunity to Join Cytokinetics, Incorporated Fraud Investigation with the Schall Law Firm
May 02, 2025
From
The Schall Law Firm
Via
Business Wire
FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months
↗
May 02, 2025
FDA extended the aficamten decision deadline to Dec. 26 after classifying the REMS submission as a major amendment to the NDA review.
Via
Benzinga
Cytokinetics, Incorporated Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - CYTK
May 02, 2025
From
DJS Law Group
Via
Business Wire
Block, Atlassian, Apple, Roku, Amazon And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
May 02, 2025
Via
Benzinga
Get insights into the top gainers and losers of Thursday's after-hours session.
↗
May 01, 2025
The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
May 01, 2025
Via
Benzinga
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday
↗
April 24, 2025
Via
Benzinga
Bristol Myers Analyst Says FDA Update Is A Win For Camzyos With Simpler Use, Broader Reach
↗
April 21, 2025
FDA approves Camzyos label update easing echo monitoring and lifting drug interaction limits, supported by 3.5 years of safety data and real-world use
Via
Benzinga
Which stocks are moving after the closing bell on Wednesday?
↗
April 16, 2025
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
April 16, 2025
Via
Benzinga
Why Is US Pharma Giant Bristol Myers Squibb Stock Trading Lower On Tuesday?
↗
April 15, 2025
Bristol Myers' Camzyos missed goals in a Phase 3 nHCM trial, showing no significant benefits over placebo but raised no new safety concerns.
Via
Benzinga
Applied Digital Posts Weak Revenue, Joins Allegro MicroSystems And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
April 15, 2025
Via
Benzinga
Bristol Myers Slumps On Heart Drug Failure — Taking Cytokinetics With It
↗
April 14, 2025
The companies are facing off with their heart drugs in a growing disease area.
Via
Investor's Business Daily
Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday
↗
April 02, 2025
Via
Benzinga
Why Edgewise Therapeutics And Cytokinetics Stocks Just Diverged
↗
April 02, 2025
Edgewise Therapeutics stock dropped, as Cytokinetics shares got a big boost early Wednesday.
Via
Investor's Business Daily
Topics
Bankruptcy
Scholastic Posts Strong Earnings, Joins Ouster, Torrid Holdings, Adaptive Biotechnologies And Other Big Stocks Moving Higher On Friday
↗
March 21, 2025
Via
Benzinga
MGM Resorts To Rally Around 75%? Here Are 10 Top Analyst Forecasts For Thursday
↗
February 13, 2025
Via
Benzinga
This AstraZeneca Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
↗
February 13, 2025
Via
Benzinga
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
↗
January 22, 2025
Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, despite investor concerns over M&A and deals.
Via
Benzinga
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
↗
January 22, 2025
Via
Benzinga
Why Cytokinetics Stock Was a Nearly 5% Winner Today
↗
December 20, 2024
Via
The Motley Fool
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
↗
November 08, 2024
Via
Benzinga
Netflix To $650? Here Are 10 Top Analyst Forecasts For Wednesday
↗
October 09, 2024
Via
Benzinga
Analysts Think There's Still Time to Get in on Edgewise, Up 332%
September 25, 2024
Edgewise Therapeutics was a massive winner last week after positive results on its cardiovascular treatment. This there still room for the stock to run?
Via
MarketBeat
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
